To further validate the association between the overexpression of osteonectin and prostate carcinogenesis in clinical specimens, immunohistochemical (IHC) analysis was performed on a prostate tissue microarray containing 40 primary prostate tumors and 9 matched normal prostate samples. Here, SPARC is linked to prostate neoplasm.